Bioactive Small Molecules in Disease Research: Applications & High-Quality Products by ANT BIO PTE. LTD
Bioactive small molecules refer to compounds with biological activity that have a molecular weight of less than 1000 Da (especially less than 500 Da). Unlike cytokines and proteins, small molecules can penetrate cell membranes to enter cells and exert corresponding biological functions. With numerous protein targets, bioactive small molecules have been widely applied in many important research fields of life sciences, such as oncology, immunology, neurobiology, epigenetics, stem cells, organoids, apoptosis, ion channels, and signal transduction. This article systematically summarizes the classification, mechanism of action of bioactive small molecules, their typical application cases in disease research, and recommends high-performance related products from ANT BIO PTE. LTD. to support in-depth scientific research.
1. Classification and Mechanism of Action of Bioactive Small Molecules
Bioactive small molecules mainly exert their effects by regulating the activity of their protein targets. Currently, the protein targets of small molecules mainly include three categories: enzymes, ion channels, and receptors. The specific classification and corresponding mechanisms of action are detailed in the following table:
|
Classification |
Mechanism of Action |
|
Enzyme Inhibitor |
Binds to the active site of enzymes or proteins, reducing the catalytic activity of enzymes or the function of proteins. |
|
Channel Blocker |
Prevents the opening of ion channels, mainly including voltage-gated channels (such as Ca²⁺, K⁺, Na⁺ channels, etc.) and ligand-gated channels (such as GABA receptors, 5-HT receptors, Ach receptors, etc.). |
|
Receptor Agonist, Antagonist & Reverse Agonist |
Receptors are activated after binding to their ligands to transmit signals. Agonists bind to receptors and exert the same effect as ligands. Antagonists have no effect when acting on receptors alone, but can antagonize the effect of agonists on receptors in the presence of agonists. Reverse agonists have the opposite effect to agonists. |
2.1 Case 1: Application of Brefeldin A in Tumor Immunotherapy Research
In tumor immunotherapy research, the bioactive small molecule Brefeldin A is used to block the transport of cytokines. In the study of isolation of mouse primary T cells and analysis of effector function, to detect the secretion of cytokines interferon-γ (IFN-γ), tumor necrosis factor (TNF) and granzyme B (GzmB), researchers treated cells with 5 μg/mL Brefeldin A for 5 hours before cell harvest to block cytokine transport.
Reference: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy[J]. Nature Communications, 2023, 14(1). DOI:10.1038/s41467-023-38605-3. Impact Factor (IF): 17.694.

2.2 Case 2: Application of Genistein in Regulating Aging Intestinal Homeostasis
In the research on regulating aging intestinal homeostasis, the bioactive small molecule Genistein is used as a dietary supplement to improve intestinal dysfunction in mice. Researchers used wild-type aging mice and Zmpste24-/- progeroid mice to study the role of Genistein in the lifespan and homeostasis of the aging intestine in mammals. They found that dietary Genistein can increase the level of short-chain fatty acids derived from the microbiota, regulate the homeostasis of the aging intestine, and extend healthspan and lifespan. In addition, the link between Genistein and the intestinal microbiota provides a theoretical basis for dietary intervention in age-related frailty.
Reference: Dietary genistein increases microbiota-derived short chain fatty acid levels, modulates homeostasis of the aging gut, and extends healthspan and lifespan[J]. Pharmacological Research, 2023. DOI:10.1016/j.phrs.2023.106676. Impact Factor (IF): 10.334.
2.3 Case 3: Application of SB203580 in Exploring the Role of SIRPα in Lung Cancer Growth
In the study of exploring the role of SIRPα in lung cancer growth, the bioactive small molecule SB203580 is used as a p38 MAPK pathway inhibitor. Researchers established lung cancer models in wild-type (WT) and Sirpα knockout mice (KO) by subcutaneous injection of Lewis mouse lung cancer cells. The phenotype and phagocytic function of macrophages and neutrophils were analyzed by flow cytometry. Studies have shown that SIRPα reduces the phagocytic function of M1 subtype macrophages through the SHP-1/p38 MAPK/STAT3 signaling pathway.
Reference: Lack of SIRP-alpha reduces lung cancer growth in mice by promoting anti-tumour ability of macrophages and neutrophils[J]. Cell Proliferation. 2022. DOI: 10.1111/cpr.13361. Impact Factor (IF): 8.755.

2. Typical Application Cases of Bioactive Small Molecules in Disease Research
3. Application Prospects of Bioactive Small Molecules
Bioactive small molecules have broad application prospects in disease research. They can be used in multiple fields such as drug discovery, pharmacological research, disease model establishment, as well as gene and cell therapy. By deeply understanding the characteristics and functions of bioactive small molecules, as well as their advantages and value in disease research, we can better recognize their important position in scientific research. It is expected that bioactive small molecules will bring more breakthroughs to the fields of scientific research and disease treatment.

4. Recommended Products by ANT BIO PTE. LTD.
To support researchers in in-depth studies on bioactive small molecules, ANT BIO PTE. LTD. provides a series of high-quality related products that have undergone strict quality control and verification. The detailed product information is shown in the following table:
|
Cat. No. |
Product Name |
CAS No. |
Product Description |
|
abs810002 |
SB 203580 |
152121-47-6 |
A selective ATP-competitive p38 MAPK inhibitor |
|
abs810004 |
Genistein |
446-72-0 |
A multi-target tyrosine kinase inhibitor |
|
abs810012 |
Brefeldin A |
20350-15-6 |
Blocks the transport of secretory proteins and membrane proteins from the endoplasmic reticulum to the Golgi apparatus |
|
abs810466 |
Cisplatin |
15663-27-1 |
An anti-tumor chemotherapeutic agent; can activate ferroptosis and induce autophagy |
|
abs810744 |
Erastin |
571203-78-6 |
A ferroptosis inducer |
|
abs812852 |
PMSF |
329-98-6 |
An irreversible serine/cysteine protease inhibitor for the preparation of cell lysates |